United-Guardian 报告称，第一季度收益为 63 万美元，净销售额有所增长，但面临股价下跌。 United-Guardian reports Q1 earnings of $0.63 million, a rise in net sales, but faces stock price drop.

United-Guardian 报告第一季度收益为 0.11 美元，净收入为 63 万美元，尽管报告发布后股价跌至 9.50 美元。 United-Guardian reported Q1 earnings with an EPS of $0.11 and a net income of $0.63 million, despite a stock price drop to $9.50 following the report. 该公司以化妆品和制药产品著称,其股票被StockNews.com评级为“买”。 The company, known for its cosmetic and pharmaceutical products, saw its stock rated "buy" by StockNews.com. 在2024财政年度,由于化妆品成分和医疗润滑油销售量增加,尽管药品销售量下降了5%,但2024财政年度,United-Guardian的销售净额增加了12%,净收入比上一年增加了28%。 For FY 2024, United-Guardian saw a 12% rise in net sales and a 28% increase in net income compared to the previous year, driven by higher sales of cosmetic ingredients and medical lubricants, though pharmaceutical sales fell by 5%.